The development and manufacturing of life-saving pharmaceuticals rely heavily on specialized chemical intermediates. Among these, 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid, bearing the CAS number 376608-65-0, holds significant importance, particularly in the realm of cardiovascular medicine. This compound serves as a vital building block in the synthesis of Ticagrelor, a potent antiplatelet medication that plays a crucial role in managing patients with Acute Coronary Syndrome (ACS).

Ticagrelor's mechanism of action involves inhibiting the P2Y12 receptor, thereby preventing platelet aggregation. This action is critical in reducing the risk of thrombotic cardiovascular events, including heart attacks and strokes. The precise molecular structure of the intermediate, 376608-65-0, is instrumental in achieving the desired stereochemistry and functionality required for Ticagrelor's pharmacological activity. Manufacturers who supply this intermediate must ensure a high degree of chemical purity and stereochemical integrity.

The typical specifications for this pharmaceutical intermediate, as indicated by leading chemical suppliers, highlight its white to off-white powder appearance and an assay purity ranging from 98.0% to 102.0%. These parameters are not merely descriptive; they are stringent quality control checkpoints that guarantee the intermediate's suitability for pharmaceutical applications. A deviation from these standards could lead to compromised reaction yields, unwanted by-products, and ultimately, affect the safety and efficacy of the final drug product.

For pharmaceutical companies, securing a reliable supply of CAS 376608-65-0 is a strategic imperative. This involves identifying manufacturers with robust production capabilities, adherence to Good Manufacturing Practices (GMP), and a proven track record of quality. Companies often seek suppliers who can offer competitive pricing, especially for large-scale manufacturing, and who can provide consistent, long-term availability. This is where understanding the global supplier landscape, particularly identifying manufacturers in regions like China, becomes beneficial for cost optimization without sacrificing quality.

When engaging with potential suppliers, it is essential to inquire about their capacity to deliver required quantities and their commitment to quality assurance. Discussions about packaging, such as the standard 15KG/fiber drum, and appropriate storage conditions are also part of the procurement process. The ability to obtain technical support, detailed product specifications, and timely delivery are hallmarks of a trusted pharmaceutical intermediate supplier.

In summary, the intermediate with CAS 376608-65-0 is more than just a chemical compound; it is a critical enabler in the production of essential cardiovascular drugs. Its stringent quality requirements underscore the importance of careful supplier selection, ensuring that pharmaceutical manufacturers have access to the high-purity materials needed to improve global health outcomes.